High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: A Cross-Sectional Cohort Study

Journal of Travel Medicine

Volumn 22, Issue 5, 2015, Pages 292-299

  Epelboin, Loïc ^a,b,c   Robert, Jérôme ^b,c   Tsyrina Kouyoumdjian, Ellina ^a   Laouira, Sonia ^c   Meyssonnier, Vanina ^a   Caumes, Eric ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Assistance publique Hôpitaux de Paris   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

AFRICA; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASIA; ASYMPTOMATIC INFECTION; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CARRIER; BONE INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CARRIER; EGYPT; ESCHERICHIA COLI; EUROPE; FECES ANALYSIS; FEMALE; FRANCE; GASTROINTESTINAL INFECTION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; MIGRANT; MULTIDRUG RESISTANCE; NORTH AFRICA; PREVALENCE; RESPIRATORY TRACT INFECTION; RETURNING TRAVELER; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; TRAVEL; URINARY TRACT INFECTION; VIRUS INFECTION; WESTERN HEMISPHERE; ADULT; DISEASE TRANSMISSION; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; INFECTION CONTROL; ISOLATION AND PURIFICATION; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; ASIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TRAVEL; YOUNG ADULT;

EID: 84941184830     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12211     Document Type: Article

References (29)

1. Deresinski S,. In the Literature-Travels with ESBLs. Clin Infect Dis 2011; 52: iii-iv.
2. Woodford N,. Unwanted souvenirs: travel and multi-resistant bacteria. J Travel Med 2011; 18: 297-298.
3. Lepelletier D, Andremont A, Grandbastien B,. Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread. J Travel Med 2011; 18: 344-351.
4. Haut Conseil de la santé publique. Maîtrise de la diffusion des bactéries multirésistantes aux antibiotiques importées en France par des patients rapatriés ou ayant des antécédents d'hospitalisation à l'étranger. Collection Avis et Rapports 2010: 41. Available at: www.hcsp.fr/explore.cgi/hcspr20101116-bmrimport.pdf. (Accessed 2015 Apr 20).
5. Peirano G, Laupland KB, Gregson DB, Pitout JD,. Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med 2011; 18: 299-303.
6. Weisenberg SA, Mediavilla JR, Chen L, et al., Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City. PLoS One 2012; 7: e45141.
7. Tangden T, Cars O, Melhus A, Lowdin E,. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother 2010; 54: 3564-3568.
8. Ostholm-Balkhed A, Tarnberg M, Nilsson M, et al., Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother 2013; 68: 2144-2153.
9. Paltansing S, Vlot JA, Kraakman ME, et al., Extended-spectrum beta-lactamase-producing Enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis 2013; 19: 1206-1213.
10. von Wintersdorff CJ, Penders J, Stobberingh EE, et al., High rates of antimicrobial drug resistance gene acquisition after international travel, The Netherlands. Emerg Infect Dis 2014; 20: 649-657.
11. Ruppe E, Armand-Lefevre L, Estellat C, et al., Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Euro Surveill 2014; 19: pii: 20768.
12. Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, et al., 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother 2013; 68: 562-568.
13. Ruppe E, Pitsch A, Tubach F, et al., Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards. Eur J Clin Microbiol Infect Dis 2012; 31: 319-325.
14. Vento TJ, Cole DW, Mende K, et al., Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan. BMC Infect Dis 2013; 13: 68.
15. Kantele A, Laaveri T, Mero S, et al., Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing enterobacteriaceae. Clin Infect Dis 2015; 60: 837-846.
16. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL,. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis 2011; 53: 49-56.
17. Kumarasamy KK, Toleman MA, Walsh TR, et al., Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
18. Woerther PL, Burdet C, Chachaty E, Andremont A,. Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 2013; 26: 744-758.
19. Tschudin-Sutter S, Frei R, Dangel M, et al., Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis 2012; 55: 1505-1511.
20. Freeman JT, McBride SJ, Heffernan H, et al., Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clin Infect Dis 2008; 47: 689-692.
21. Soraas A, Sundsfjord A, Sandven I, et al., Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae-a case-control study in a low prevalence country. PLoS One 2013; 8: e69581.
22. Kuster SP, Hasse B, Huebner V, et al., Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection 2010; 38: 33-40.
23. Islam S,. High rates of ESBL-producing Escherichia coli in young children who traveled recently to India. Pediatr Infect Dis J 2012; 31: 1103.
24. Williamson DA, Masters J, Freeman J, Roberts S,. Travel-associated extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infection following transrectal ultrasound-guided prostate biopsy. BJU Int 2012; 109: E21-E22.
25. Colodner R, Kometiani I, Chazan B, Raz R,. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 2008; 36: 41-45.
26. Wayenberg L, Epelboin L, London J, et al., Infection urinaire à Escherichia coli producteur de bêta-lactamase à spectre étendu chez un voyageur au retour d'Asie du Sud-Est. Bull Soc Pathol Exot 2012; 106: 1-4.
27. Peirano G, Pitout JD,. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35: 316-321.
28. Zahar JR, Lecuit M, Carbonnelle E, et al., Is it time to reconsider initial antibiotic treatment strategies for severe urinary tract infections in Europe? Clin Microbiol Infect 2007; 13: 219-221.
29. Leibovici L, Vidal L, Paul M,. Aminoglycoside drugs in clinical practice: an evidence-based approach. J Antimicrob Chemother 2009; 63: 246-251.